Abstract
Cancers inflict the largest burden in the world. Burden of Cancer incidence and mortality is also growing. Hematopoietic stem cell transplantation (HSCT) is a curative therapeutic method for malignant hematologic disorders and is associated with early and late treatment related mortality. Cardiac toxicity and cardiovascular consequences are not common in post HSCT patients compared to other HSCT related complications. However, these complications play an important role in survivors’ outcome. It is necessary to identify and decrease these life-threatening complications to improve patients’ outcome and decline related cost burden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CAD:
-
Coronary artery disease
- CHF:
-
Congestive heart failure
- CNS:
-
Central nervous system
- CVRF:
-
Cardiovascular risk factor
- CVD:
-
Cardiovascular disease
- DALYs:
-
Disability adjusted life years
- GBD:
-
Global burden of disease
- GVHD:
-
Graft versus host disease
- HM:
-
Hematological malignancy
- HSCT:
-
Hematopoietic stem cell transplantation
- PE:
-
Pericardial effusion
- SVTA:
-
Supraventricular tachyarrhythmia
- TBI:
-
Total body irradiation
- WHO:
-
World health organization
References
Alizadehasl A, Fini H. Thrombotic events in cancer patients.2023. https://doi.org/10.5772/intechopen.109619
Alizadehasl A, Ghadimi N, Hosseinifard H, Roudini K, Emami AH, Ghavamzadeh A, et al. Cardiovascular diseases in patients after hematopoietic stem cell transplantation: systematic review and meta-analysis. Current Res Translational Med. 2023;71(1):103363. https://doi.org/10.1016/j.retram.2022.103363
Armenian SH, Sun C-L, Vase T, Ness KK, Blum E, Francisco L, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 2012;120(23):4505–12. https://doi.org/10.1182/blood-2012-06-437178.
Armenian SH, Chemaitilly W, Chen M, Chow EJ, Duncan CN, Jones LW, et al. National institutes of health hematopoietic cell transplantation late effects initiative: the cardiovascular disease and associated risk factors working group report. Biol Blood Marrow Transp. 2017;23(2):201–10. https://doi.org/10.1016/j.bbmt.2016.08.019.
Armenian SH, Chow EJ. Cardiovascular disease in survivors of hematopoietic cell transplantation. Cancer. 2014 Feb 15;120(4):469–79. https://doi.org/10.1002/cncr.28444. Epub 2013 Oct 25
Auberle C, Lenihan D, Gao F, et al. Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival. Cardio-Oncol. 2023;9(1). https://doi.org/10.1186/s40959-022-00150-1
Balassa K, Danby, R, Rocha, V. Haematopoietic stem cell transplants: principles and indications. British J Hosp Med.2019;80(1):33–9. https://doi.org/10.12968/hmed.2019.80.1.33.
Chen L, Zheng Y, Yu K, et al. Changing causes of death in persons with haematological cancers 1975–2016. Leukemia. 2022;36:1850–60. https://doi.org/10.1038/s41375-022-01596-z.
Hidalgo J, Krone R, Rich M, et al. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transp. 2004;34:615–9. https://doi.org/10.1038/sj.bmt.1704623.
Keykhaei M, Masinaei M, Mohammadi E, et al. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017. Exp Hematol Oncol. 2021;10:11. https://doi.org/10.1186/s40164-021-00198-2.
Krok-Schoen L, Fisher JL, Stephens JA, Mims A, Ayyappan S, et al. Incidence and survival of hematological cancers among adults ages ≥ 75 years. Cancer Med. 2018;7(7):3425–33. https://doi.org/10.1002/cam4.1461
Kubo H, Imataki O, Fukumoto T, Oku M, Ishida T, et al. Risk factors for and the prognostic impact of pericardial effusion after allogeneic hematopoietic stem cell transplantation. Transp Cell Therapy.2021;27(11):949.e1–8
Liu Y-C, Chien S-H, Fan N-W, Hu M-H, Gau J-P, et al. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2015;169:737–45. https://doi.org/10.1111/bjh.13357.
Mattiuzzi C, Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019;9(4):217–22. https://doi.org/10.2991/jegh.k.191008.001.
Passweg JR, Baldomero H, Chabannon C, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transp. 2021;56:1651–64. https://doi.org/10.1038/s41409-021-01227-8.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.
Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, et al. Infectious Diseases Working Party EBMT. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):126–136. https://doi.org/10.1038/s41409-019-0624-z. Epub 2019 Aug 27
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Tichelli A, Rovó A, Gratwohl A. Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematology Am Soc Hematol Educ Program. 2008;2008(1):125–33. https://doi.org/10.1182/asheducation-2008.1.125.
Tichelli A, Bhatia S, Socié G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol. 2008;142(1):11–26. https://doi.org/10.1111/j.1365-2141.2008.07165.x.
Tonorezos ES, Stillwell EE, Calloway JJ, Glew T, Wessler JD, et al. Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transp. 2015;50(9):1212–6. https://doi.org/10.1038/bmt.2015.127. Epub 2015 Jun 1.
Turk A, Liu J, Jamshed U, et al. Arrhythmia in bone marrow transplant: why we should worry. J Am Coll Cardiol. 2019;73(9_Supplement_1):500. https://doi.org/10.1016/S0735-1097(19)31108-8
Versluys AB, Grotenhuis HB, Boelens MJJ, et al. Predictors and outcome of pericardial effusion after hematopoietic stem cell transplantation in children. Pediatr Cardiol. 2018;39:236–44. https://doi.org/10.1007/s00246-017-1747-x.
Ward ZJ, Scott AM, Hricak H, Atun R. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis. Lancet Oncol. 2021;22(3):341–50. https://doi.org/10.1016/S1470-2045(20)30750-6.
Zhao Y, He R, Oerther S, Zhou W, Vosough M, Hassan M. Cardiovascular complications in hematopoietic stem cell transplanted patients. J Pers Med. 2022;12(11):1797. https://doi.org/10.3390/jpm12111797.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Emami, A.H., Alizadehasl, A., Noohi Bezanjani, F., Hajiali, H. (2024). Burden of Cardiovascular Disease in HSCT. In: Alizadehasl, A., Ghavamzadeh, A., Emami, A.H., Janbabaei, G., Khoda-Amorzideh, D. (eds) Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation . Springer, Cham. https://doi.org/10.1007/978-3-031-53659-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-53659-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-53658-8
Online ISBN: 978-3-031-53659-5
eBook Packages: MedicineMedicine (R0)